Free Trial

Rice Hall James & Associates LLC Purchases 73,300 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

The Pennant Group logo with Medical background

Rice Hall James & Associates LLC increased its position in shares of The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 43.8% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 240,649 shares of the company's stock after buying an additional 73,300 shares during the quarter. Rice Hall James & Associates LLC owned about 0.69% of The Pennant Group worth $6,052,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Balance Wealth LLC acquired a new stake in shares of The Pennant Group in the 1st quarter worth about $317,000. SG Americas Securities LLC boosted its stake in The Pennant Group by 56.9% during the 1st quarter. SG Americas Securities LLC now owns 23,413 shares of the company's stock valued at $589,000 after purchasing an additional 8,490 shares during the last quarter. NBC Securities Inc. bought a new position in shares of The Pennant Group in the first quarter valued at approximately $25,000. Rhumbline Advisers grew its holdings in The Pennant Group by 8.6% during the first quarter. Rhumbline Advisers now owns 47,423 shares of the company's stock worth $1,193,000 after buying an additional 3,750 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in The Pennant Group by 7,124.5% during the first quarter. GAMMA Investing LLC now owns 7,947 shares of the company's stock worth $200,000 after buying an additional 7,837 shares in the last quarter. Institutional investors own 85.88% of the company's stock.

The Pennant Group Price Performance

The Pennant Group stock traded up $0.12 during mid-day trading on Monday, hitting $25.35. 172,069 shares of the company traded hands, compared to its average volume of 216,976. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.41 and a current ratio of 1.41. The Pennant Group, Inc. has a one year low of $21.18 and a one year high of $37.13. The stock has a market cap of $873.81 million, a price-to-earnings ratio of 33.36, a price-to-earnings-growth ratio of 2.14 and a beta of 1.51. The stock has a fifty day moving average price of $28.13 and a 200-day moving average price of $26.48.

Insider Buying and Selling at The Pennant Group

In other news, Director Joanne Stringfield sold 5,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $29.47, for a total value of $147,350.00. Following the completion of the sale, the director directly owned 30,275 shares in the company, valued at approximately $892,204.25. The trade was a 14.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 5.40% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on PNTG. Wells Fargo & Company boosted their target price on The Pennant Group from $30.00 to $31.00 and gave the stock an "equal weight" rating in a research note on Tuesday, June 3rd. Truist Financial boosted their price objective on The Pennant Group from $28.00 to $32.00 and gave the stock a "hold" rating in a research report on Monday, May 12th. Finally, Stephens reaffirmed an "overweight" rating and set a $35.00 target price on shares of The Pennant Group in a research report on Tuesday, June 10th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $34.60.

View Our Latest Stock Analysis on The Pennant Group

The Pennant Group Profile

(Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

See Also

Institutional Ownership by Quarter for The Pennant Group (NASDAQ:PNTG)

Should You Invest $1,000 in The Pennant Group Right Now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines